DUXAP9 and cancer: Moreover, LNMAT1 is significantly overexpressed in various types of human cancer, such as bladder, prostate, kidney, colon, lung, and liver cancer (19), which also means that LNMAT1 may be a potential therapeutic target for clinical intervention in metastatic cancer.